%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/2162402X.2020.1868122
Oral administration of Bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12
Qingxiang Li
Yuke Li
Yifei Wang
Le Xu
Yuxing Guo
Yixiang Wang
Lin Wang
Chuanbin Guo
Taylor & Francis
OncoImmunology, 2021. doi:10.1080/2162402X.2020.1868122
Bifidobacterium breve
interleukin 12
dendritic cells
solid tumor
intestinal microbiota
en
Journal
OncoImmunology
© 2021 The Author(s). Published with license by Taylor & Francis Group, LLC.
2162-402X
10
1
10.1080/2162402X.2020.1868122
https://doi.org/10.1080/2162402X.2020.1868122
VoR
application/pdfdoi:10.1080/2162402X.2020.186812210.1080/2162402X.2020.1868122https://doi.org/10.1080/2162402X.2020.18681222021-01-15truewww.tandfonline.com10.1080/2162402X.2020.1868122www.tandfonline.comtrue2021-01-1510.1080/2162402X.2020.1868122
endstream
endobj
4 0 obj
<>stream
xI$5^`.jEpZ8f@ÅYYh!F}ppѫxolX~z nq%d/-֥.Ͽ8!K\5އZ-/b;۵zOK#pV!OY:}OQae&xaFkO=4cៅ -ْq%#+haB=Y,^E6f^
Taq Ed?rާ"taX #><-ШT#J1|fROp&5evmTygSSӭ??"^n\X
/?p~^``n`J4Ӵ /qWϿz˟xjN,x}5,YT|X]Qcq틐bJuxꝩpy]?D$ esǡ6Cԩ'DCq^T]t?O{ʴ
ާBd(β~oeR6@J=)ห<7}}'U`C-uTs(&vuJߔS
)$*_,n,(j\7q$x)]H8Ę$¡C6m쀰VZs4I`?|GOIQ&mO9YۘEr[ 8ŦGuGF$^$X$+Άy(;XJm%Eqj֗b{3_RWF\r6%0Ms\;s^\R(fnU0"0Ajfo*2!,{; C [
2:qC@ƚܝQV6 eeͧ BڑbcSt*pzDÍoۓajIx:=6b͢;Ϙf١4{4z'U9KRc͝MSQaK`-Z.J^JĶiA}졜}e_l:{=GaRZnw{ھX&O?M8)#{-F+U/)ӺV2ip$f8n7XrkwuKݬ!-2\owc*cYxb]R/ܗz5qK[vhY5{Uuw.nyZ8d)r'ӄH>mf]Z[ZJMVZ>-H`]s(ns3t¡չWsDxs*Jc9&/>ZRKQ4cgF2pI9=nJ4KB}Ú4pQd[wkYܝƶ~_:T1x'TEw5|kC?s̬8*G[,ʽRN3iqj=?Ov/f͆`\y:=oH`K",J>stream
xwXSsN`$!l{@ ٢ $@TR)XZԉ(
RZD|y L0V@(#q `= nnWXX0+Зȕ;ѫ R1{Ol (Lγx\䜙/V'LKP0RX~@9k(8u?̰yBOΑr y
<)_Έ"<?_l)
F+s9H
MI #~__ Q$.R$sŅg%f,a6GTLΟEQԖ!/Bſ)EogEA?l kJ^-ؒ \?l{ P&d\EAt{6~/ÇfJq2bFn6g0<8aO"yD|TyE